Brawn Biotech Quarterly Results
Brawn Biotech quarterly results. In Mar 2023, Brawn Biotech (BRAWN) reported revenue ₹0 Cr and net profit ₹0 Cr. For annual financials, live price and key ratios, visit Brawn Biotech stock price NSE.
BRAWN Quarterly Results — Revenue, Profit & EPS Highlights
Brawn Biotech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review BRAWN earnings multiple to evaluate earnings-based valuation against sector peers.
- Operating Margin of 25.0% in Mar 2023 (+58.0pp vs Jun 2023)
- Earnings Per Share of ₹0.47 in Mar 2023 (+687.5% vs Jun 2023)
Brawn Biotech Quarterly Results — Revenue, EBITDA, Net Profit & EPS
BRAWN quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2023 | Jun 2023 | Jun 2022 | QoQ | YoY |
|---|---|---|---|---|---|
| Revenue (₹ Cr) | 0 | 0 | 0 | - | - |
| Net Profit (₹ Cr) | 0 | 0 | 0 | - | - |
| EBITDA (₹ Cr) | 0 | 0 | 0 | - | - |
| EPS (₹) | 0.47 | -0.08 | 0.05 | - | - |
| Operating Margin (%) | 25.0% | -33.0% | 25.0% | - | - |
BRAWN Share Price Trend — 1-Year Movement Across Quarterly Results
Brawn Biotech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check Brawn Biotech market worth to track the company's total market size over time.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
BRAWN vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Brawn Biotech latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹432,120.23 Cr | 1779.7 | 15,018 | 2,710 | -5.6% | - | 18.0% | 157.5 |
|
Divis Laboratories
Mar 2026 |
₹253,522.49 Cr | 9196.0 | 2,986 | 751 | -5.0% | - | 25.2% | 324.8 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹188,719.51 Cr | 4772.0 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 414.6 |
|
Zydus Life Science
Mar 2026 |
₹113,615.69 Cr | 1139.0 | 7,569 | 1,341 | -4.3% | - | 17.7% | 90.0 |
|
Cipla
Mar 2026 |
₹108,576.18 Cr | 1335.5 | 6,612 | 543 | -9.3% | - | 8.2% | 194.4 |
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores